EFTA00684232

From: Terje Rod-Larsen
To: Jeffrey Epstein <Jeevacation@gmail.com> 
Subject: Fwd: Alzheimers 
Date: Thu, 30 Jan 2014 12:53:40 +0000 
Sent from my iPhone 
Begin forwarded message: 
From: Walter Kemp <kemp@lpharg> 
Date: January 27, 2014 at 7:32:15 PM GMT+1 
To: Terje Rod-Larsen 
Cc: Camilla Reksten-Monsen 
Subject: Fw: Alzheimers 
Terje, 
I hope this information on Alzheimer's can be helpful. 
Walter 
 
Original Message 
From: Andrea Pfeifer [mailto: 
Sent: Sunday, January 26, 2014 03:38 AM Eastern Standard Time 
To: Walter Kemp 
Subject: RE: Alzheimers 
Dear Walter, 
Really nice to meet you. 
The drug, an Anti-Abeta antibody (Anti-Plaues,) is the first drug in a preventive AD study and runs under the 
name of Crenezumab. This study is supported by NIH. There are other studies on the same molecule together 
with Genentech, i.e. phase 2 studies of efficacy and biomarkers. 
You will find a lot of information on our web or Internet. 
Please let me know if you have specific questions and I am happy to provide you the answers. 
Best 
Andrea 
Prof. Andrea Pfeifer 
CEO 
EFTA00684232

AC Immune SA 
EPFL Innovation Park (please note our new address) 
Building B 
CH-1015 Lausanne 
Phone: +41 21 693 91 23 
Mobile: 
Fax: 
+41 21 
E-mail: 
693 91 20 
This e-mail message is confidential and for use of the intended recipient(s) only. This communication may 
contain information that is proprietary, privileged or confidential or otherwise legally exempt from 
disclosure. Unauthorized use or treatment of all or part of this message is strictly prohibited. Unintended 
recipients: please notify the sender and delete the original message, any attachments and any copies from your 
computer and back-up system immediately. Thank you. 
Original Message 
From: Walter Kemp 
Sent: 24 January 2014 14:18 
To: Andrea Pfeifer 
Subject: Alzheimers 
Dear Dr. Pfeifer, 
We met briefly on the train yesterday on the way to Davos. 
You mentioned that your company had produced a drug to counter-act Alzheimers. Could you give me its 
name? 
Thanks very much and all the best with your important work. 
Sincerely, 
Walter Kemp (Canadian, based in Vienna) 
International Peace Institute 
EFTA00684233